IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $653,000 | -51.6% | 14,770 | -59.5% | 0.04% | -38.5% |
| Q2 2022 | $1,349,000 | -37.5% | 36,447 | -37.5% | 0.06% | -46.3% |
| Q1 2022 | $2,159,000 | +34.1% | 58,292 | +10.2% | 0.12% | +101.7% |
| Q4 2021 | $1,610,000 | -7.8% | 52,907 | +1.6% | 0.06% | -33.3% |
| Q3 2021 | $1,747,000 | +126.3% | 52,084 | +169.0% | 0.09% | +172.7% |
| Q2 2021 | $772,000 | +181.8% | 19,360 | +299.8% | 0.03% | +43.5% |
| Q4 2020 | $274,000 | -52.8% | 4,842 | -60.5% | 0.02% | -63.5% |
| Q3 2020 | $581,000 | +15.7% | 12,245 | +43.7% | 0.06% | -24.1% |
| Q2 2020 | $502,000 | -49.1% | 8,519 | -59.2% | 0.08% | -30.8% |
| Q1 2020 | $987,000 | +197.3% | 20,881 | +279.7% | 0.12% | +344.4% |
| Q4 2019 | $332,000 | -48.2% | 5,500 | -48.6% | 0.03% | -30.8% |
| Q3 2019 | $641,000 | – | 10,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |